122 related articles for article (PubMed ID: 36288885)
21. Pentoxifylline inhibits lipopolysaccharide-induced inflammatory mediators in human second trimester placenta explants.
Speer EM; Lin X; Murthy A; Hou W; Islam S; Hanna N
Placenta; 2017 Oct; 58():60-66. PubMed ID: 28962697
[TBL] [Abstract][Full Text] [Related]
22. Immune response modulation by pentoxifylline in vitro.
Tilg H; Eibl B; Pichl M; Gächter A; Herold M; Brankova J; Huber C; Niederwieser D
Transplantation; 1993 Jul; 56(1):196-201. PubMed ID: 8333042
[TBL] [Abstract][Full Text] [Related]
23. Differential modulation of IL-8 and TNF-alpha expression in human keratinocytes by buflomedil chlorhydrate and pentoxifylline.
Redondo P; García-Foncillas J; España A; Cuevillas F; Quintanilla E
Exp Dermatol; 1997 Aug; 6(4):186-94. PubMed ID: 9293391
[TBL] [Abstract][Full Text] [Related]
24. The inhibition of pro-inflammatory cytokines with pentoxifylline in the cardiopulmunary bypass lung.
Ustünsoy H; Sivrikoz MC; Bakir K; Senkaya ; Erbagci B; Uçak R; Nurözler F
Respir Med; 2002 Apr; 96(4):275-9. PubMed ID: 12000008
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of the beneficial effects of pentoxifylline during sepsis: maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines.
Koo DJ; Yoo P; Cioffi WG; Bland KI; Chaudry IH; Wang P
J Surg Res; 2000 Jun; 91(1):70-6. PubMed ID: 10816353
[TBL] [Abstract][Full Text] [Related]
26. [Immunomodulatory effect of pentoxifylline in Graves ophthalmopathy].
Balázs C; Kiss E; Vámos A; Molnár I; Farid NR
Orv Hetil; 1997 Nov; 138(45):2869-74. PubMed ID: 9432636
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.
Schandené L; Vandenbussche P; Crusiaux A; Alègre ML; Abramowicz D; Dupont E; Content J; Goldman M
Immunology; 1992 May; 76(1):30-4. PubMed ID: 1385797
[TBL] [Abstract][Full Text] [Related]
28. The effect of pentoxifylline (PTX) on Theiler's murine encephalomyelitis (TMEV)-induced demyelinating disease.
Fushimi T; Inoue A; Koh CS; Yamazaki M; Ishihara Y; Kim BS
Cell Immunol; 1998 Jun; 186(2):140-6. PubMed ID: 9665756
[TBL] [Abstract][Full Text] [Related]
29. Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion.
Fossat C; Fabre D; Alimi Y; Bienvenu J; Aillaud MF; Lenoble M; Juhan-Vague I; Juhan C
J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S96-100. PubMed ID: 8699873
[TBL] [Abstract][Full Text] [Related]
30. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
Chen YM; Lin SL; Chiang WC; Wu KD; Tsai TJ
Kidney Int; 2006 Apr; 69(8):1410-5. PubMed ID: 16541021
[TBL] [Abstract][Full Text] [Related]
31. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.
Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA
AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037
[TBL] [Abstract][Full Text] [Related]
32. Hepatorenal protection in renal ischemia/reperfusion by celecoxib and pentoxifylline.
Farag MM; Khalifa AA; Elhadidy WF; Rashad RM
J Surg Res; 2016 Jul; 204(1):183-91. PubMed ID: 27451885
[TBL] [Abstract][Full Text] [Related]
33. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory activity modulation by hypertonic saline and pentoxifylline in a rat model of strangulated closed loop small bowel obstruction.
Rasslan R; Utiyama EM; Marques GM; Ferreira TC; da Costa VA; de Victo NC; Rasslan S; Montero EF
Int J Surg; 2014; 12(6):594-600. PubMed ID: 24797690
[TBL] [Abstract][Full Text] [Related]
35. Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice.
Queiroz-Junior CM; Bessoni RL; Costa VV; Souza DG; Teixeira MM; Silva TA
Life Sci; 2013 Sep; 93(9-11):423-8. PubMed ID: 23911669
[TBL] [Abstract][Full Text] [Related]
36. Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines.
Ji Q; Zhang L; Jia H; Xu J
Ann Clin Lab Sci; 2004; 34(4):427-36. PubMed ID: 15648785
[TBL] [Abstract][Full Text] [Related]
37. Effects of pentoxifylline on the cytokines that may play a role in rejection and resistive index in renal transplant recipients.
Demir E; Paydas S; Balal M; Kurt C; Sertdemir Y; Erken U
Transplant Proc; 2006 Nov; 38(9):2883-6. PubMed ID: 17112855
[TBL] [Abstract][Full Text] [Related]
38. Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats.
Lundblad R; Ekstrøm P; Giercksky KE
Shock; 1995 Mar; 3(3):210-5. PubMed ID: 7773801
[TBL] [Abstract][Full Text] [Related]
39. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
Tukov FF; Luyendyk JP; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
[TBL] [Abstract][Full Text] [Related]
40. Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporin A.
Funk JO; Ernst M; Schönharting MM; Zabel P
Int J Immunopharmacol; 1995 Dec; 17(12):1007-16. PubMed ID: 8964650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
